Gerrit Los
Impact in
- Oncology top 1%
- PARP inhibition in cancer therapy
- Lung Cancer Research Studies
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
-
- DNA Repair Mechanisms 8
- Cancer therapeutics and mechanisms 7
- Melanoma and MAPK Pathways 6
- Oncology 35
- HER2/EGFR in Cancer Research 7
- Metal complexes synthesis and properties 7
- Co-authors
- J. G. McVie (13 shared papers)Maria E. Arango (6 shared papers)James G. Christensen (4 shared papers)Barbara Mroczkowski (3 shared papers)P.H.A. Mutsaers (6 shared papers)Joseph H. Lee (3 shared papers)Qiuhua Li (3 shared papers)Shinji Yamazaki (3 shared papers)
- Journals
- Cancer Research (11 papers)Cancer Chemotherapy and Pharmacology (9 papers)British Journal of Cancer (6 papers)Molecular Cancer Therapeutics (5 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Gerrit Los
96 papers receiving 4.2k citations
Gerrit Los's Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 1.5k
- Reproductive Medicine 395
- Otorhinolaryngology 155
- Hepatology 273
- Pulmonary and Respiratory Medicine 923
Countries citing papers authored by Gerrit Los
This map shows the geographic impact of Gerrit Los's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit Los with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit Los more than expected).
Fields of papers citing papers by Gerrit Los
This network shows the impact of papers produced by Gerrit Los. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit Los. The network helps show where Gerrit Los may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerrit Los, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms Hit paper breakdown → | 2007 | 617 |
| 2 | Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma Hit paper breakdown → | 2007 | 544 |
| 3 | 2010 | 216 | |
| 4 | 2010 | 201 | |
| 5 | 1991 | 155 | |
| 6 | 1994 | 128 | |
| 7 | Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. | 1989 | 124 |
| 8 | 1990 | 119 | |
| 9 | 1994 | 114 | |
| 10 | 2005 | 109 | |
| 11 | 2003 | 106 | |
| 12 | 1991 | 101 | |
| 13 | 2009 | 94 | |
| 14 | 2013 | 86 | |
| 15 | 1999 | 85 | |
| 16 | Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats. | 1989 | 85 |
| 17 | 1996 | 72 | |
| 18 | A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity. | 1992 | 64 |
| 19 | 1997 | 62 | |
| 20 | 2010 | 61 |
About Gerrit Los
Gerrit Los is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Surgery and Pulmonary and Respiratory Medicine, having authored 99 papers that have together received 4.4k indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (14 papers), Intraperitoneal and Appendiceal Malignancies (11 papers), DNA Repair Mechanisms (8 papers), HER2/EGFR in Cancer Research (7 papers), Cancer therapeutics and mechanisms (7 papers), Metal complexes synthesis and properties (7 papers), Microtubule and mitosis dynamics (6 papers) and Melanoma and MAPK Pathways (6 papers). The work is most often cited by research in Oncology (1.5k citations), Reproductive Medicine (395 citations), Otorhinolaryngology (155 citations), Hepatology (273 citations) and Pulmonary and Respiratory Medicine (923 citations). Gerrit Los has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include J. G. McVie, Maria E. Arango, James G. Christensen, Barbara Mroczkowski, P.H.A. Mutsaers, Joseph H. Lee, Qiuhua Li, Shinji Yamazaki, Helen Y. Zou and Gordon Alton. Their work appears in journals such as Cancer Research, Cancer Chemotherapy and Pharmacology, British Journal of Cancer, Molecular Cancer Therapeutics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.